Public-registry site landscape for NCT03258398, a Microsatellite Stable Relapsed or Refractory Colorectal Cancer study sponsored by Effector Therapeutics. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03258398 (registry record) |
| Sponsor | Effector Therapeutics |
| Condition(s) | Microsatellite Stable Relapsed or Refractory Colorectal Cancer |
| Phase | PHASE2 |
| Listed sites | 7 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT03258398 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →